Firefly Neuroscience (AIFF) Net Shares Issued and Repurchased (2012 - 2025)
Firefly Neuroscience (AIFF) posted Net Shares Issued and Repurchased of $141562.0 for Q4 2025, up 843.75% on a QoQ basis from $15000.0 in Q1 2025, and down 57.83% year-over-year from $335728.0 in Q4 2024.
Analysis
Firefly Neuroscience (AIFF) Net Shares Issued and Repurchased (2012 - 2025) Analysis & Trends
Firefly Neuroscience has reported Net Shares Issued and Repurchased for 14 years, with the latest figure at $141562.0 in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased fell 57.83% year-over-year to $141562.0 in Q4 2025; TTM through Dec 2025 was $141562.0, a 57.83% decrease from a year earlier, with the FY2025 full-year figure at $141562.0, down 57.83% from the prior year.
- Net Shares Issued and Repurchased was $141562.0 for Q4 2025 at Firefly Neuroscience, up from $15000.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $2.0 million in Q4 2021, with the low at $15000.0 in Q1 2025.
- Average Net Shares Issued and Repurchased over 5 years is $363434.8, with a median of $143281.0 recorded in 2021.
- The sharpest annual moves came in 2021 and 2022: Net Shares Issued and Repurchased surged 1175.0% in 2021, then sank 90.15% in 2022.
- Over 5 years, Net Shares Issued and Repurchased stood at $2.0 million in 2021, then tumbled by 90.15% to $195200.0 in 2022, then tumbled by 55.17% to $87500.0 in 2023, then soared by 283.69% to $335728.0 in 2024, then plunged by 57.83% to $141562.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $141562.0 (Q4 2025), $15000.0 (Q1 2025), and $335728.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 6.20 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | - |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | - |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | - |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 141,562.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 335,728.00 |
| Sep 30, 2024 | 335,728.00 |
| Dec 31, 2023 | 87,500.00 |
| Dec 31, 2022 | 195,200.00 |
| Sep 30, 2022 | 53,500.00 |
| Mar 31, 2022 | 912,000.00 |
| Dec 31, 2021 | 1.98 Mn |
| Sep 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 127,500.00 |
| Mar 31, 2021 | 145,000.00 |
| Dec 31, 2020 | 235,000.00 |
| Sep 30, 2020 | 210,000.00 |
| Jun 30, 2020 | 10,000.00 |
| Mar 31, 2020 | 129,000.00 |
| Dec 31, 2019 | 15,500.00 |
| Dec 31, 2018 | 166,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 30,000.00 |